Michael Maris, MD, is a Member Physician and Director of Research at the Colorado Blood Cancer Institute and part of the Myeloid and Lymphoid Disease Groups. Dr. Maris has been a member of CBCI since 2003. Dr. Maris specializes in the treatment of patients with blood cancers and holds strong expertise in the use of blood and marrow transplantation for hematologic malignancies. Dr. Maris is board certified in medical oncology.

Dr. Maris was born in Eastern Ohio and raised both in Central New Jersey and North of Pittsburgh. He received his undergraduate degree at West Virginia University. He worked in the laboratory of Dr. Britton Chance at the University of Pennsylvania developing noninvasive near-infrared modalities to assess tissue oxygenation and physiologic and disease states.

Dr. Maris received his medical degree from the University of Pennsylvania. He completed his internal medicine residency at the Oregon Health Sciences University in Portland, Oregon. Dr. Maris completed his oncology and blood and marrow transplantation fellowship at the Fred Hutchinson Cancer Research Center/University of Washington in Seattle, Washington. Dr. Maris' research focus at that time was expanding the role of allogeneic transplantation to older and infirm patients through the use of non-myeloablative allogeneic hematopoietic stem cell transplantation. Dr. Maris has published extensively in this area.

Dr. Maris' current research interests are in further optimizing allogeneic hematopoietic transplantation for patients of all types as well as the development of novel drug and drug regimens for the treatment of the patients with acute myeloid leukemia. Dr. Maris has extensive experience as an investigator in multiple clinical trials and Dr. Maris has expertise in the treatment of patients with acute myeloid leukemia.

He believes that physicians are educators/guides during the cancer treatment process and patients should be empowered with the knowledge to guide their decisions. Patient understanding of the underlying disease process and therapeutic options is a requirement in the shared clinical decision making between the patient and his/her physician.

Dr. Maris enjoys spending time with his family. In his free time he enjoys hiking, skiing, running, biking, and travel.


Medical School
University of Pennsylvania School of Medicine

Oregon Health & Science University Hospital

Hutchinson Cancer Research Center/University of Washington





Office Locations

Colorado Blood Cancer Institute
1721 E 19th Ave
Suites 200 & 300
Denver, CO 80218
Phone: (720) 754-4800
Fax: (866) 341-6984